Software enhances visualization of dense breasts

Article

OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.

OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.

Running in concert with visualization features built into Siemens' syngo-based workstations, OpView can be used to adjust the display of images to concentrate on areas of high interest, such as the borders of the breast and subtle masses, or to adjust brightness and contrast for optimal display of images.

The software decreases the quantum and electronic noise from x-rays that can interfere with the evaluation of suspicious lesions, particularly abnormalities that are low in contrast. An edge enhancement feature enhances high frequencies in an image to increase the visibility of structures such as microcalcifications.

In addition to the multimodality Mammomat Novation syngo-based acquisition workstation, OpView can be used with the MammoReport workstation, which incorporates computer-aided detection (CAD) markers from various vendors.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging's Weekly Scan: August 11 — August 17 (Video Version)
A Closer Look at the Impact of Expanded Mammography Coverage in Missouri: An Interview with Amy Patel, MD
New Mammography Research Examines Impact of High-Resolution DBT
© 2025 MJH Life Sciences

All rights reserved.